Grab your cup of coffee and kick off the week with some Odds and Ends: Late last year, Pfizer (PFE) announced it was considering its ‘options’ for its consumer health division. The early buzz was all about a sale though and the maker of Advil and Centrum has since been running a sales process with a rumored desired… Read More »
Reckitt Benckiser (RBGLY) surprised the markets last week with its $16.6b (or $90 per share) bid for Enfamil maker and 2009 Bristol-Myers Squibb split off Mead Johnson Nutrition (MJN). Reckitt is known for owning a hodgepodge of ‘Powerbrands’ such as Lysol, Finish, Durex and Clearasil in the Health, Hygiene and Home sectors so it wasn’t really considered much of a… Read More »
Supposedly addicts make great repeat customers, but unfortunately for Reckitt Benckiser (OTC:RBGLY), they (or at least insurers and pharmacies) are quite price sensitive. That seems to be one of the underlying reasons behind the consumer brand giant’s recent announcement of plans to spin off its pharmaceuticals business. The majority of the units’ $1.3b in revenues come from sales of… Read More »